WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience New products for neuroscience research
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (164)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stefanis, L.
Right arrow Articles by Greene, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stefanis, L.
Right arrow Articles by Greene, L. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DOPAMINE

 Previous Article  |  Next Article 

The Journal of Neuroscience, December 15, 2001, 21(24):9549-9560

Expression of A53T Mutant But Not Wild-Type alpha -Synuclein in PC12 Cells Induces Alterations of the Ubiquitin-Dependent Degradation System, Loss of Dopamine Release, and Autophagic Cell Death

Leonidas Stefanis1, 2, Kristin E. Larsen2, Hardy J. Rideout2, David Sulzer2, 3, and Lloyd A. Greene1

Departments of 1 Pathology, 2 Neurology, and 3 Psychiatry, Columbia University, New York, New York 10032

alpha -Synuclein mutations have been identified in certain families with Parkinson's disease (PD), and alpha -synuclein is a major component of Lewy bodies. Other genetic data indicate that the ubiquitin-dependent proteolytic system is involved in PD pathogenesis. We have generated stable PC12 cell lines expressing wild-type or A53T mutant human alpha -synuclein. Lines expressing mutant but not wild-type alpha -synuclein show: (1) disruption of the ubiquitin-dependent proteolytic system, manifested by small cytoplasmic ubiquitinated aggregates and by an increase in polyubiquitinated proteins; (2) enhanced baseline nonapoptotic death; (3) marked accumulation of autophagic-vesicular structures; (4) impairment of lysosomal hydrolysis and proteasomal function; and (5) loss of catecholamine-secreting dense core granules and an absence of depolarization-induced dopamine release. Such findings raise the possibility that the primary abnormality in these cells may involve one or more deficits in the lysosomal and/or proteasomal degradation pathways, which in turn lead to loss of dopaminergic capacity and, ultimately, to death. These cells may serve as a model to study the effects of aberrant alpha -synuclein on dopaminergic cell function and survival.

Key words: Parkinson's disease; Lewy body; ubiquitin; autophagy; proteasome; lysosome; dopamine


Copyright © 2001 Society for Neuroscience  0270-6474/01/21249549-12$05.00/0


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
E. Kyratzi, M. Pavlaki, and L. Stefanis
The S18Y polymorphic variant of UCH-L1 confers an antioxidant function to neuronal cells
Hum. Mol. Genet., July 15, 2008; 17(14): 2160 - 2171.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Liao, Y. Yao, J. Liu, Z. Yu, S. Cheung, A. Xie, X. Liang, and X. Bi
Cholesterol Accumulation Is Associated with Lysosomal Dysfunction and Autophagic Stress in Npc1 / Mouse Brain
Am. J. Pathol., September 1, 2007; 171(3): 962 - 975.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. A. Gonzalez-Polo, M. Niso-Santano, M. A. Ortiz-Ortiz, A. Gomez-Martin, J. M. Moran, L. Garcia-Rubio, J. Francisco-Morcillo, C. Zaragoza, G. Soler, and J. M. Fuentes
Inhibition of Paraquat-Induced Autophagy Accelerates the Apoptotic Cell Death in Neuroblastoma SH-SY5Y Cells
Toxicol. Sci., June 1, 2007; 97(2): 448 - 458.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. L. Toth, P. Simon, A. L. Kovacs, and T. Vellai
Influence of autophagy genes on ion-channel-dependent neuronal degeneration in Caenorhabditis elegans
J. Cell Sci., March 15, 2007; 120(6): 1134 - 1141.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. D. Gitler and J. Shorter
Prime Time for {alpha}-Synuclein
J. Neurosci., March 7, 2007; 27(10): 2433 - 2434.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. W. Dickson
Linking Selective Vulnerability to Cell Death Mechanisms in Parkinson's Disease
Am. J. Pathol., January 1, 2007; 170(1): 16 - 19.
[Full Text] [PDF]


Home page
J. Neurosci.Home page
K. E. Larsen, Y. Schmitz, M. D. Troyer, E. Mosharov, P. Dietrich, A. Z. Quazi, M. Savalle, V. Nemani, F. A. Chaudhry, R. H. Edwards, et al.
{alpha}-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis.
J. Neurosci., November 15, 2006; 26(46): 11915 - 11922.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. R. Mazzulli, A. J. Mishizen, B. I. Giasson, D. R. Lynch, S. A. Thomas, A. Nakashima, T. Nagatsu, A. Ota, and H. Ischiropoulos
Cytosolic Catechols Inhibit {alpha}-Synuclein Aggregation and Facilitate the Formation of Intracellular Soluble Oligomeric Intermediates
J. Neurosci., September 27, 2006; 26(39): 10068 - 10078.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. V. Mosharov, R. G. W. Staal, J. Bove, D. Prou, A. Hananiya, D. Markov, N. Poulsen, K. E. Larsen, C. M. H. Moore, M. D. Troyer, et al.
{alpha}-Synuclein Overexpression Increases Cytosolic Catecholamine Concentration
J. Neurosci., September 6, 2006; 26(36): 9304 - 9311.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
G. MAUCELI, C. I BUSCETI, A. PELLEGRINI, P. SOLDANI, P. LENZI, A. PAPARELLI, and F. FORNAI
Overexpression of {alpha}-Synuclein following Methamphetamine: Is It Good or Bad?
Ann. N.Y. Acad. Sci., August 1, 2006; 1074: 191 - 197.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Cao, J. A. Espinola, E. Fossale, A. C. Massey, A. M. Cuervo, M. E. MacDonald, and S. L. Cotman
Autophagy Is Disrupted in a Knock-in Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis
J. Biol. Chem., July 21, 2006; 281(29): 20483 - 20493.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. St. P. McNaught, T. Jackson, R. JnoBaptiste, A. Kapustin, and C. W. Olanow
Proteasomal dysfunction in sporadic Parkinson's disease
Neurology, May 23, 2006; 66(10_suppl_4): S37 - S49.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. W. Shults
Lewy bodies
PNAS, February 7, 2006; 103(6): 1661 - 1668.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
W. W. Smith, H. Jiang, Z. Pei, Y. Tanaka, H. Morita, A. Sawa, V. L. Dawson, T. M. Dawson, and C. A. Ross
Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity
Hum. Mol. Genet., December 15, 2005; 14(24): 3801 - 3811.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
A. KELEKAR
Autophagy
Ann. N.Y. Acad. Sci., December 1, 2005; 1066(1): 259 - 271.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Iwata, J. C. Christianson, M. Bucci, L. M. Ellerby, N. Nukina, L. S. Forno, and R. R. Kopito
Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation
PNAS, September 13, 2005; 102(37): 13135 - 13140.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. W. Bertoncini, C. O. Fernandez, C. Griesinger, T. M. Jovin, and M. Zweckstetter
Familial Mutants of {alpha}-Synuclein with Increased Neurotoxicity Have a Destabilized Conformation
J. Biol. Chem., September 2, 2005; 280(35): 30649 - 30652.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Chen, J. Thorpe, and J. N. Keller
{alpha}-Synuclein Alters Proteasome Function, Protein Synthesis, and Stationary Phase Viability
J. Biol. Chem., August 26, 2005; 280(34): 30009 - 30017.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S M Hague, S Klaffke, and O Bandmann
Neurodegenerative disorders: Parkinson's disease and Huntington's disease
J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1058 - 1063.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. B. Cole, D. D. Murphy, J. Lebowitz, L. Di Noto, R. L. Levine, and R. L. Nussbaum
Metal-catalyzed Oxidation of {alpha}-Synuclein: HELPING TO DEFINE THE RELATIONSHIP BETWEEN OLIGOMERS, PROTOFIBRILS, AND FILAMENTS
J. Biol. Chem., March 11, 2005; 280(10): 9678 - 9690.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
L. Stefanis
Caspase-Dependent and -Independent Neuronal Death: Two Distinct Pathways to Neuronal Injury
Neuroscientist, February 1, 2005; 11(1): 50 - 62.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
B. Martin-Clemente, B. Alvarez-Castelao, I. Mayo, A. B. Sierra, V. Diaz, M. Milan, I. Farinas, T. Gomez-Isla, I. Ferrer, and J. G. Castano
{alpha}-Synuclein Expression Levels Do Not Significantly Affect Proteasome Function and Expression in Mice and Stably Transfected PC12 Cell Lines
J. Biol. Chem., December 17, 2004; 279(51): 52984 - 52990.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
A. SIDHU, C. WERSINGER, C. E-H. MOUSSA, and P. VERNIER
The Role of {alpha}-Synuclein in Both Neuroprotection and Neurodegeneration
Ann. N.Y. Acad. Sci., December 1, 2004; 1035(1): 250 - 270.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
T. Shintani and D. J. Klionsky
Autophagy in Health and Disease: A Double-Edged Sword
Science, November 5, 2004; 306(5698): 990 - 995.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. J. Rideout, P. Dietrich, Q. Wang, W. T. Dauer, and L. Stefanis
{alpha}-Synuclein Is Required for the Fibrillar Nature of Ubiquitinated Inclusions Induced by Proteasomal Inhibition in Primary Neurons
J. Biol. Chem., November 5, 2004; 279(45): 46915 - 46920.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
A. M. Cuervo, L. Stefanis, R. Fredenburg, P. T. Lansbury, and D. Sulzer
Impaired Degradation of Mutant {alpha}-Synuclein by Chaperone-Mediated Autophagy
Science, August 27, 2004; 305(5688): 1292 - 1295.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
C. A. Wilson, D. D. Murphy, B. I. Giasson, B. Zhang, J. Q. Trojanowski, and V. M.-Y. Lee
Degradative organelles containing mislocalized {alpha}- and {beta}-synuclein proliferate in presenilin-1 null neurons
J. Cell Biol., May 10, 2004; 165(3): 335 - 346.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. SIDHU, C. WERSINGER, and P. VERNIER
Does {alpha}-synuclein modulate dopaminergic synaptic content and tone at the synapse?
FASEB J, April 1, 2004; 18(6): 637 - 647.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Lindersson, R. Beedholm, P. Hojrup, T. Moos, W. Gai, K. B. Hendil, and P. H. Jensen
Proteasomal Inhibition by {alpha}-Synuclein Filaments and Oligomers
J. Biol. Chem., March 26, 2004; 279(13): 12924 - 12934.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H.-J. Lee, F. Khoshaghideh, S. Patel, and S.-J. Lee
Clearance of {alpha}-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway
J. Neurosci., February 25, 2004; 24(8): 1888 - 1896.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
Z.-H. Qin, Y. Wang, K. B. Kegel, A. Kazantsev, B. L. Apostol, L. M. Thompson, J. Yoder, N. Aronin, and M. DiFiglia
Autophagy regulates the processing of amino terminal huntingtin fragments
Hum. Mol. Genet., December 15, 2003; 12(24): 3231 - 3244.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
T. F. Outeiro and S. Lindquist
Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology
Science, December 5, 2003; 302(5651): 1772 - 1775.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. C. J. Lang-Rollin, H. J. Rideout, M. Noticewala, and L. Stefanis
Mechanisms of Caspase-Independent Neuronal Death: Energy Depletion and Free Radical Generation
J. Neurosci., December 3, 2003; 23(35): 11015 - 11025.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Fortun, W. A. Dunn Jr, S. Joy, J. Li, and L. Notterpek
Emerging Role for Autophagy in the Removal of Aggresomes in Schwann Cells
J. Neurosci., November 19, 2003; 23(33): 10672 - 10680.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
T. M. Dawson and V. L. Dawson
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Science, October 31, 2003; 302(5646): 819 - 822.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Guimaraes, M. Benchimol, G. P. Amarante-Mendes, and R. Linden
Alternative Programs of Cell Death in Developing Retinal Tissue
J. Biol. Chem., October 24, 2003; 278(43): 41938 - 41946.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. Dong, B. Ferger, J.-C. Paterna, D. Vogel, S. Furler, M. Osinde, J. Feldon, and H. Bueler
Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1
PNAS, October 14, 2003; 100(21): 12438 - 12443.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. Fornai, P. Lenzi, M. Gesi, M. Ferrucci, G. Lazzeri, C. L. Busceti, R. Ruffoli, P. Soldani, S. Ruggieri, M. G. Alessandri, et al.
Fine Structure and Biochemical Mechanisms Underlying Nigrostriatal Inclusions and Cell Death after Proteasome Inhibition
J. Neurosci., October 1, 2003; 23(26): 8955 - 8966.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J.-M. Itier, P. Ibanez, M. A. Mena, N. Abbas, C. Cohen-Salmon, G. A. Bohme, M. Laville, J. Pratt, O. Corti, L. Pradier, et al.
Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse
Hum. Mol. Genet., September 15, 2003; 12(18): 2277 - 2291.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Webb, B. Ravikumar, J. Atkins, J. N. Skepper, and D. C. Rubinsztein
{alpha}-Synuclein Is Degraded by Both Autophagy and the Proteasome
J. Biol. Chem., June 27, 2003; 278(27): 25009 - 25013.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. J. Rideout, Q. Wang, D. S. Park, and L. Stefanis
Cyclin-Dependent Kinase Activity Is Required for Apoptotic Death But Not Inclusion Formation in Cortical Neurons after Proteasomal Inhibition
J. Neurosci., February 15, 2003; 23(4): 1237 - 1245.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Allen, P. R. Heath, J. Kirby, S. B. Wharton, M. R. Cookson, F. M. Menzies, R. E. Banks, and P. J. Shaw
Analysis of the Cytosolic Proteome in a Cell Culture Model of Familial Amyotrophic Lateral Sclerosis Reveals Alterations to the Proteasome, Antioxidant Defenses, and Nitric Oxide Synthetic Pathways
J. Biol. Chem., February 14, 2003; 278(8): 6371 - 6383.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
E. J. Ryu, H. P. Harding, J. M. Angelastro, O. V. Vitolo, D. Ron, and L. A. Greene
Endoplasmic Reticulum Stress and the Unfolded Protein Response in Cellular Models of Parkinson's Disease
J. Neurosci., December 15, 2002; 22(24): 10690 - 10698.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Lotharius, S. Barg, P. Wiekop, C. Lundberg, H. K. Raymon, and P. Brundin
Effect of Mutant alpha -Synuclein on Dopamine Homeostasis in a New Human Mesencephalic Cell Line
J. Biol. Chem., October 4, 2002; 277(41): 38884 - 38894.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. G. Perez, J. C. Waymire, E. Lin, J. J. Liu, F. Guo, and M. J. Zigmond
A Role for alpha -Synuclein in the Regulation of Dopamine Biosynthesis
J. Neurosci., April 15, 2002; 22(8): 3090 - 3099.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-